ConductScience.org, home

Paper831074

Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice.

Toyka KV and 6 others. N Engl J Med, 1977. Cited by 379 papers, by iCite.

Cite this record

ConductScience Library. Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice. Papers, record 831074. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/831074

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice.
PubMed
Journal
N Engl J Med
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
379
iCite
Relative citation ratio, by iCite
9.75
iCite
Revised in PubMed
2013-11-21
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Toyka KVK V
2Drachman DBD B
3Griffin DED E
4Pestronk AA
5Winkelstein JAJ A
6Fishbeck KHK H
7Kao II

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ImmunityMajor topic
Immunization, PassiveMajor topic
Myasthenia GravisMajor topic
Acetylcholine
Adolescent
Adult
Aged
Animals
Autoimmune Diseases
Complement C3
Complement C5
Female
Humans
Immunoglobulin G
Immunoglobulin M
Male
Membrane Potentials
Mice
Middle Aged
Neuromuscular Junction
Receptors, Cholinergic

Source PubMed

Download CSV of topics

Cited by89

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 379 citations.

PMIDTitleJournalYearIn PapersSource
42920067Current and Emerging Therapies for Generalized Myasthenia Gravis: Toward Precision Medicine.Neurol Ther2026https://conductscience.org/library/papers/42920067PubMed
42321519Narcolepsy is (not) an autoimmune disease.Nat Rev Neurol2026https://conductscience.org/library/papers/42321519PubMed
41118207Therapeutic IgG- and IgM-specific proteases disarm the acetylcholine receptor autoantibodies that drive myasthenia gravis pathology.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/41118207PubMed
41006369Refinement of the rat acetylcholine receptor-specific passive transfer myasthenia gravis model using subcutaneous injections: an update to the guidelines.Sci Rep2025https://conductscience.org/library/papers/41006369PubMed
40612406Fibromyalgia syndrome-am I an autoimmune condition?Pain Rep2025https://conductscience.org/library/papers/40612406PubMed
40257679Real-World Experience with FcRn Inhibitors Efgartigimod and Rozanolixizumab in Myasthenia Gravis: Administration in Multiple Cycles and Transition from Intravenous to Subcutaneous Formulation.Neurol Ther2025https://conductscience.org/library/papers/40257679PubMed
39111891Efgartigimod Successfully Ameliorated Acute Exacerbation of Myasthenia Gravis with Anti-muscle-specific Kinase Antibodies.Intern Med2025https://conductscience.org/library/papers/39111891PubMed
37559106Milestones in the history of neurocritical care.Neurol Res Pract2023https://conductscience.org/library/papers/37559106PubMed
36362622New Targeted Agents in Myasthenia Gravis and Future Therapeutic Strategies.J Clin Med2022https://conductscience.org/library/papers/36362622PubMed
36074148Receptor clustering and pathogenic complement activation in myasthenia gravis depend on synergy between antibodies with multiple subunit specificities.Acta Neuropathol2022https://conductscience.org/library/papers/36074148PubMed
34426685Getting specific: targeting Fc receptors in myasthenia gravis.Nat Rev Neurol2021https://conductscience.org/library/papers/34426685PubMed
34196305Passive transfer of fibromyalgia symptoms from patients to mice.J Clin Invest2021https://conductscience.org/library/papers/34196305PubMed
32582144Complement Inhibitor Therapy for Myasthenia Gravis.Front Immunol2020https://conductscience.org/library/papers/32582144PubMed
32116982In vivo Mechanisms of Antibody-Mediated Neurological Disorders: Animal Models and Potential Implications.Front Neurol2019https://conductscience.org/library/papers/32116982PubMed
31482201Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review.J Neurol2021https://conductscience.org/library/papers/31482201PubMed
30953561Anti-CNTN1 IgG3 induces acute conduction block and motor deficits in a passive transfer rat model.J Neuroinflammation2019https://conductscience.org/library/papers/30953561PubMed
29089519Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient.Sci Rep2017https://conductscience.org/library/papers/29089519PubMed
28620373Mechanisms of Autoantibody-Induced Pathology.Front Immunol2017https://conductscience.org/library/papers/28620373PubMed
26977423Immunoadsorption therapy in autoimmune encephalitides.Neurol Neuroimmunol Neuroinflamm2016https://conductscience.org/library/papers/26977423PubMed
26886206Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society.J Neurol2016https://conductscience.org/library/papers/26886206PubMed

See all 89 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
C3718PubTator's text mininghttps://conductscience.org/library/genes/718NCBI Gene
C5727PubTator's text mininghttps://conductscience.org/library/genes/727NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/831074

GET https://conductscience.org/api/papers/v1/831074/cited_by?page=2